Integra Lifesciences Holdings IART
NASDAQ IART
$16.74 +0.15 (+0.90%)
At close: Aug 21, 2026 · 4:00 PM EDT

Integra Lifesciences Holdings (IART) Land & Improvements (2010 - 2011)

Integra Lifesciences Holdings (IART) posted Land & Improvements of $2.7 million for Q4 2011, down 0.62% sequentially from $2.7 million in Q4 2010, and down 0.62% YoY from $2.7 million in Q4 2010.

Integra Lifesciences Holdings (IART) Land & Improvements (2010 - 2011) Analysis & Trends

Integra Lifesciences Holdings has reported Land & Improvements for 2 years, with the latest figure at $2.7 million in Q4 2011.

  • Quarterly Land & Improvements fell 0.62% year-over-year to $2.7 million in Q4 2011, while the trailing twelve-month figure through Dec 2011 was $2.7 million (down 0.62% YoY) and the FY2011 annual result came in at $2.7 million, down 0.62% from the prior year.
  • Land & Improvements slipped to $2.7 million in Q4 2011 per IART's latest filing, from $2.7 million in the prior quarter.
  • Over five years, Land & Improvements peaked at $2.7 million in Q4 2010 and troughed at $2.7 million in Q4 2011.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Land & Improvements (Qtr)
1 Abbott Laboratories 202.72 Bn 197.12 Bn 7.27 Bn -
2 Stryker 126.42 Bn 122.94 Bn 4.50 Bn 1.81 Bn
3 Medtronic 119.75 Bn 110.53 Bn 6.41 Bn -
4 Boston Scientific 74.13 Bn 73.60 Bn 3.85 Bn 183.00 Mn
5 Edwards Lifesciences 51.78 Bn 47.53 Bn 1.35 Bn -
6 Dexcom 35.29 Bn 33.34 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.95 Bn 31.85 Bn 2.18 Bn -
8 Koninklijke Philips 26.22 Bn 22.90 Bn 4.55 Bn -
9 Steris 23.21 Bn 22.73 Bn 684.20 Mn 112.50 Mn
10 Integra Lifesciences Holdings 1.29 Bn 1.02 Bn 219.74 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2011 2.71 Mn
Dec 31, 2010 2.73 Mn